Literature DB >> 6982140

Heterogeneity of T-CLL defined by monoclonal antibodies in nine patients.

F Pandolfi, G Semenzato, G De Rossi, D M Strong, I Quinti, A Pezzutto, F Mandelli, F Aiuti.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6982140     DOI: 10.1016/0090-1229(82)90004-6

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


× No keyword cloud information.
  6 in total

1.  Phenotype study with monoclonal antibodies of T lymphocyte colonies in normal individuals and in patients with chronic OKT8+ lymphocytic leukaemia.

Authors:  C Andre; J P Farcet; N Oudhriri; M F Gourdin; J Bouguet; F Reyes
Journal:  Clin Exp Immunol       Date:  1983-11       Impact factor: 4.330

2.  Classification of patients with T-cell chronic lymphocytic leukemia and expansions of granular lymphocytes: heterogeneity of Italian cases by a multiparameter analysis.

Authors:  F Pandolfi; F Mandelli; G Semenzato; A Ranucci; F Aiuti
Journal:  J Clin Immunol       Date:  1984-05       Impact factor: 8.317

3.  HNK-1 monoclonal antibody (Leu-7) in the identification of abnormal expansions of large granular lymphocytes.

Authors:  F Pandolfi; G Semenzato; G de Rossi; I Quinti; C Guglielmi; A Pezzutto; M Lopez; G Tonietti; L Fontana; T Abo; F Aiuti
Journal:  Clin Exp Immunol       Date:  1983-06       Impact factor: 4.330

4.  T gamma lymphocytosis is clinically non-progressive but immunologically heterogeneous.

Authors:  F Miedema; F G Terpstra; J W Smit; J P van der Veen; C J Melief
Journal:  Clin Exp Immunol       Date:  1985-08       Impact factor: 4.330

5.  Inhibition of bone marrow colony formation by human natural killer cells and by natural killer cell-derived colony-inhibiting activity.

Authors:  G Degliantoni; B Perussia; L Mangoni; G Trinchieri
Journal:  J Exp Med       Date:  1985-05-01       Impact factor: 14.307

Review 6.  Biology of natural killer cells.

Authors:  G Trinchieri
Journal:  Adv Immunol       Date:  1989       Impact factor: 3.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.